Experimental Hematology
Volume 36, Issue 11 , Pages 1436-1448 , November 2008

Molecular profiling of candidate human hematopoietic stem cells derived from human embryonic stem cells

  • Farbod Shojaei

      Affiliations

    • Robarts Research Institute
    • University of Western Ontario, London, ON, Canada
    • Corresponding Author InformationOffprint requests to: Farbod Shojaei, Ph.D., Instituto de Investigaciones Bioedicas, Parque Tecnologico de la Salud, Avenida del Conocimiento s/n, Granada 18100, Spain.
    • ,
  • Pablo Menendez

      Affiliations

    • Robarts Research Institute
    • Banco Andaluz de Células Madre/University of Granada, Granada, Spain

Received 16 March 2008 ,Revised 5 May 2008 ,Accepted 2 June 2008.

References 

  1. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35–71
  2. Lemischka I. Searching for stem cell regulatory molecules. Some general thoughts and possible approaches. Ann N Y Acad Sci. 1999;872:274–287
  3. Dick JE. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol. 1996;8:197–206
  4. Larochelle A, Vormoor J, Hanenberg . H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329–1337
  5. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Bhatia M. Cytokines and BMP–4 promote hematopoietic differentiation of human embryonic stem cells. Blood. 2003;102:906–915
  6. Tian X, Woll PS, Morris JK, Linehan JL, Kaufman DS. Hematopoietic engraftment of human embryonic stem cell–derived cells is regulated by recipient innate immunity. Stem Cells. 2006;12:123–130
  7. Bueno C, Lopes LF, Greaves M, Menendez P. Toward development of a novel NOD/SCID–based in vivo strategy to model multiple myeloma pathogenesis. Exp Hematol. 2007;35:1477–1478
  8. Wang L, Menendez P, Shojaei F, et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med. 2005;201:1603–1614
  9. Murdoch B, Gallacher L, Awaraji C, et al. Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. FASEB J. 2001;15:1628–1630
  10. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged–1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med. 2000;192:1365–1372
  11. Murdoch B, Chadwick K, Martin M, et al. Wnt–5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci U S A. 2003;100:3422–3427
  12. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self–renewal of haematopoietic stem cells. Nature. 2003;423:409–414
  13. Bhatia M, Bonnet D, Wu D, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999;189:1139–1148
  14. Bhardwaj G, Murdoch B, Wu D, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol. 2001;2:172–180
  15. Eguchi–Ishimae M, Eguchi M, Kempski H, Greaves M. NOTCH1 mutation can be an early, prenatal genetic event in T–ALL. Blood. 2008;111:376–378
  16. Shojaei F, Gallacher L, Bhatia M. Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis. Blood. 2004;103:2530–2540
  17. Gallacher L, Murdoch B, Wu D, Karanu F, Fellows F, Bhatia M. Identification of novel circulating human embryonic blood stem cells. Blood. 2000;96:1740–1747
  18. Raghavachari NBP, Hong Y, Muller U. Comparison of gene expression profile of Hep G2 unamplified and amplified RNA. Ambion TechNotes. 2002;9
  19. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome–wide expression patterns. Proc Natl Acad Sci U S A. 1998;95:14863–14868
  20. Araki T, Zimonjic DB, Popescu NC, Milbrandt J. Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem. 1997;272:21373–21380
  21. Babic I, Schallhorn A, Lindberg FP, Jirik FR. SHPS–1 induces aggregation of Ba/F3 pro–B cells via an interaction with CD47. J Immunol. 2000;164:3652–3658
  22. Gawaz MP, Mujais SK, Schmidt B, Blumenstein M, Gurland HJ. Platelet–leukocyte aggregates during hemodialysis: effect of membrane type. Artif Organs. 1999;23:29–36
  23. Cao L, Yoshino T, Kawasaki N, Sakuma I, Takahashi K, Akagi T. Anti–CD53 monoclonal antibody induced LFA–1/ICAM–1–dependent and –independent lymphocyte homotypic cell aggregation. Immunobiology. 1997;197:70–81
  24. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 1995;269:1270–1272
  25. Lamb JR, Michaud WA, Sikorski RS, Hieter PA. Cdc16p Cdc23p and Cdc27p form a complex essential for mitosis. EMBO J. 1994;13:4321–4328
  26. Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, Grander D. Involvement of the Ink4 proteins p16 and p15 in T–lymphocyte senescence. Oncogene. 1998;17:595–602
  27. Meyer CA, Jacobs HW, Datar SA, Du W, Edgar BA, Lehner CF. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J. 2000;19:4533–4542
  28. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ. BID: a novel BH3 domain–only death agonist. Genes Dev. 1996;10:2859–2869
  29. Murakami–Mori K, Mori S, Bonavida B, Nakamura S. Implication of TNF receptor–I–mediated extracellular signal–regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS–associated Kaposi 's sarcoma cells: a possible role of a novel death domain protein MADD in TNF–alpha–induced ERK1/2 activation in Kaposi 's sarcoma cells. J Immunol. 1999;162:3672–3679
  30. Bendall SC, Stewart MH, Menendez P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature. 2007;448:1015–1021
  31. Aoyama K, Oritani K, Yokota T, et al. Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood. 1997;93:2586–2594
  32. Oritani K, Aoyama K, Tomiyama Y, Kincade PW, Matsuzawa Y. Stromal cell CD9 and the differentiation of hematopoietic stem/progenitor cells. Leuk Lymphoma. 2000;38:147–152
  33. Challier C, Cocault L, Berthier R, et al. The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells. Blood. 2000;100:2063–2070
  34. Bryder D, Ramsfjell V, Dybedal I, et al. Self–renewal of multipotent long–term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med. 2001;194:941–952
  35. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53–mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338–342
  36. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin–1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118:149–161
  37. Hartman MG, Lu D, Kim ML, et al. Role for activating transcription factor 3 in stress–induced beta–cell apoptosis. Mol Cell Biol. 2004;24:5721–5732
  38. Stacey D, Kazlauskas A. Regulation of Ras signaling by the cell cycle. Curr Opin Genes Dev. 2002;12:44–46
  39. Katich SC, Zerfass–Thome K, Hoffmann I. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene. Oncogene. 2001;20:543–550
  40. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62:7203–7206
  41. Kijowski J, Baj–Krzyworzeka M, Majka M, et al. The SDF–1–CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells. 2001;19:453–466
  42. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science. 2002;298:601–604
  43. Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cells fate of human embryonic stem cells originates from primitive endothelium with hemogenic properties. Immunity. 2004;21:21–31
  44. Jourdan P, Vendrell JP, Huguet MF, et al. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4 + CCR7+ human memory T cells. J Immunol. 2000;165:716–724
  45. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 1993;122:897–902
  46. Steinman RA. Cell cycle regulators and hematopoiesis. Oncogene. 2002;21:3403–3413
  47. Greaves M. Prenatal origins of childhood leukemia. Rev Clin Exp Hematol. 2003;7:233–245
  48. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3:639–649
  49. Bueno C, Montes R, García–Castro J, Greaves M, Menendez P. Human embryonic stem cells: A potential system for modeling infant leukemia harboring MLL AF4 fusion gene. Drug Discov Today. 2008;4:53–60
  50. Lensch MW, Daley GQ. Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells. Blood. 2006;107:2605–2612
  51. Bueno C, Lopes CF, Menendez P. Bone marrow stromal cell–derived Wnt signals as a potential underlying mechanism for cyclin D1 deregulation in multiple myeloma lacking t(11;14)(q13;q32). Blood Cells Mol Dis. 2007;39:366–368
  52. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004;51:1–28
  53. Ferrando AA, Look AT. Gene expression profiling in T–cell acute lymphoblastic leukemia. Semin Hematol. 2003;40:274–280
  54. Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c–MYC and activates a feed–forward–loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103:18261–18266
  55. Narayan AD, Chase JL, Lewis R, et al. Human embryonic stem cell–derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood. 2006;107:2180–2183
  56. Shojaej F, Trowbridge J, Gallacher L, et al. Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev cell. 2005;8:651–663

PII: S0301-472X(08)00265-8

doi: 10.1016/j.exphem.2008.06.001

Experimental Hematology
Volume 36, Issue 11 , Pages 1436-1448 , November 2008

Article Tools

* Image Usage & Resolution